BPAX Short Squeeze Is On

Share


This article is done by Stock Analyzer of Super Nova Alerts

Biosante Pharmaceuticals (NASDAQ:BPAX)

If you enjoy a good short squeeze play then you need to take a look at BPAX which is currently trading at $.66 cents per share which is up nearly 23% today on just under 13 million shares which is the largest volume day in several weeks.

BPAX which is a a specialty pharmaceutical company that develops products for female sexual health and oncology has soared recently as short sellers may finally be feeling the squeeze.


According to ShortSqueeze.com there are nearly 17 million shares short on BPAX currently which represents 16% of the float.

Super Nova alerts sees BPAX as a short term swing trade with a possibility of testing $.75 to $.80 in price with a tight stop loss at $.55.

With iShares Biotechnology index is up over 12 percent over the last month investors are brace for big drug launches and FDA hearings that are soon to come. This may impact BPAX significantly in the near future so check back often for more updates.

 

More Posts by this author


SuperNova
Post Written By: Super Nova

As a trader, I have spent the last 15 years navigating and scanning the penny stock markets. I don’t know anyone who has the breadth and depth of penny stock experience that I do. Through my proven methods I have consistently found some of the markets biggest and most profitable trades…and the great news is that I will share them with all of my subscribers.

Signup for my newsletter at TopStockPicks.com


Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.